Some spin · most spun: New York Post 42/100 See every outlet’s spin ↓Photo as used by Daily Mail for “New 'game changer' blood test could diagnose CTE in living athletes for first time, groundbreaking study reveals”How Daily Mail framed it: The Daily Mail’s lead image shows American football players receiving attention on the sidelines, including one near a medical tent. It connects the preliminary research to the immediate, visible risks of the sport.
Two JAMA studies found higher levels of a tau-related biomarker in samples from people with advanced CTE. The football-player study compared blood collected during life with later brain examinations. Larger studies are needed before the marker can be used to diagnose CTE reliably in living patients.
The Daily Mail and The Independent describe both studies; the New York Post concentrates on the 21-player Boston University and Banner Health study. All three report higher readings in advanced CTE and the highest readings among participants who also had Alzheimer’s-related changes. The New York Post gives more attention to symptoms and supportive care, while the Daily Mail and The Independent include an independent expert’s caution that much larger studies are needed. None of the three explicitly discusses how the male football-player brain-donor sample limits generalisation to women and other head-impact exposures.
Two studies published in JAMA have found an association between a blood biomarker and advanced chronic traumatic encephalopathy, or CTE. The findings offer a lead for research into diagnosis during life. They do not establish a validated diagnostic test that doctors can now use to confirm CTE in patients.S2R1R2R3
The Boston University and Banner Health study examined blood collected during life from 21 former American football players whose brains were later examined after death. Eighteen had CTE: sixteen with advanced disease and two with earlier-stage disease. The other three did not have CTE on examination.S2S3R1
Blood levels of the marker were higher in the advanced-CTE group. Five participants also had Alzheimer’s disease-related changes, and their levels were highest. The distinction matters because an increased reading was not confined to people with CTE alone, while low-stage CTE did not show the same elevation.S2S3R1
Why it matters
CTE currently requires examination of brain tissue after death for confirmation. Symptoms can overlap with those of other brain diseases, making assessment during life difficult. The candidate marker concerns tau, a protein that normally supports nerve cells but forms abnormal tangles in Alzheimer’s disease.S2R3
The separate Washington University research examined the tau fragment eMTBR-tau243 in a broader study of 229 participants. Its CTE blood analysis involved eleven people. Its cerebrospinal-fluid analysis also found elevated levels in Alzheimer’s disease and some inherited forms of frontotemporal degeneration, reinforcing the need to test how specifically the marker identifies CTE.S2R2
The background
The Boston study’s authors describe important limits to their sample. It consisted of male former football players recruited through a specialist research centre who subsequently donated their brains. The authors say this restricts how widely the findings can be applied, particularly to women and to other sources of repeated head impacts.R1
The small number with early-stage disease is another limitation. It restricted the researchers’ ability to determine whether the marker distinguishes early CTE from no CTE. The Washington University team likewise did not reliably identify early-stage disease in the samples described in the news reports.S2R1
What happens next
Larger studies must establish diagnostic accuracy and the ability to distinguish CTE from other conditions. In an accompanying editorial, Carla Palleis and Günter Höglinger describe possible future uses in selecting research participants and evaluating interventions, conditional on validation. Those applications remain research goals, not demonstrated benefits for patients.R1R3
Michael Alosco, a study author, said the work remained in the discovery phase. He described accurate detection and opportunities for treatment trials as prospects that depended on future studies validating the findings.S3
Fact check: every point labelled
What is confirmed, what is only reported, and what is claim or speculation. Every point links to its source.
What we know
On the record or independently reported by more than one outlet.
confirmedTwo JAMA studies identify a biomarker association with advanced CTE; it is not a validated diagnostic test.S2R1R2R3
confirmedThe Boston University and Banner Health study examined blood collected during life from 21 former American football players whose brains were later examined after death. Eighteen had CTE: sixteen with advanced disease and two with earlier-stage disease. The other three did not have CTE on examination.S2S3R1
confirmedBlood levels of the marker were higher in the advanced-CTE group. Five participants also had Alzheimer’s disease-related changes, and their levels were highest. The distinction matters because an increased reading was not confined to people with CTE alone, while low-stage CTE did not show the same elevation.S2S3R1
confirmedCTE currently requires examination of brain tissue after death for confirmation. Symptoms can overlap with those of other brain diseases, making assessment during life difficult. The candidate marker concerns tau, a protein that normally supports nerve cells but forms abnormal tangles in Alzheimer’s disease.S2R3
confirmedThe 229-participant study included eleven CTE blood cases; cerebrospinal-fluid levels also rose in Alzheimer’s disease and some inherited frontotemporal degeneration.S2R2
confirmedThe male football-player brain-donor sample limits generalisation to women and other head-impact exposures.R1
confirmedEarly-stage cases were too few to establish reliable discrimination from no CTE.S2R1
Speculation and opinion
Predictions and views, kept apart from the facts.
speculationStudy authors and JAMA editorial authors: Diagnostic accuracy, specificity and proposed clinical uses require validation.R3
speculationMichael Alosco: Michael Alosco, a study author, said the work remained in the discovery phase. He described accurate detection and opportunities for treatment trials as prospects that depended on future studies validating the findings.S3
Still unknown
Whether the biomarker can accurately distinguish CTE from other diseases in routine clinical care.
How well it detects early-stage CTE.
Whether the results generalise to women and people exposed to head impacts outside American football.
Key questions
Can a blood test now confirm CTE in a living patient?
These studies do not establish a validated diagnostic test. Definitive confirmation still requires examination after death.S2R3
How large was the football-player study?
It involved 21 former players: sixteen had advanced CTE, two had earlier-stage CTE and three had none.S2R1
Did the marker detect early-stage CTE?
The studies did not establish reliable early-stage detection. Larger and more representative studies are needed.S2R1R2
Spin meter
How each outlet framed this story, scored on the wording and choices in that article, not on the outlet’s reputation.
Headlines compared: The Daily Mail and the New York Post use the quoted phrase ‘game changer’, while The Independent calls the test a breakthrough with potential. All three point to possible diagnosis or detection in living people, though none states in the headline that the test remains unvalidated.
New York PostFraming: Not political · Spin 42/100 · Headline matches story: partly
“‘Game changer’ blood test could detect CTE in living patients for the first time”
Straight reportingHeavy spin
The New York Post emphasised the potential impact on living athletes and the severity of CTE, while also reporting that validation is a long way off.
Why? 3 framing techniques
speculation as factwill pave the way for athletes like NFL players to access the treatment they need before it’s too late This presents future clinical benefits as certain, although the test is not validated and the article says there is no treatment for CTE.
emotional appealaddiction, psychosis and violence The early focus on severe possible consequences heightens urgency around research that remains at the discovery stage.
omission The New York Post does not describe the separate 229-participant study, which included eleven CTE blood cases and findings in other diseases.
Daily MailFraming: Not political · Spin 38/100 · Headline matches story: partly
“New 'game changer' blood test could diagnose CTE in living athletes for first time, groundbreaking study reveals”
Straight reportingHeavy spin
The Daily Mail framed the research as a potential game changer for athletes, while later acknowledging its preliminary nature and diagnostic limitations.
Why? 2 framing techniques
loaded languagegroundbreaking study reveals The headline presents preliminary biomarker research as a major breakthrough, although the text says much larger studies are needed.
emphasishelping scores of football players and others avoid the degenerative brain disease The opening stresses the prospect of avoiding disease, which the studies did not establish.
The IndependentFraming: Not political · Spin 18/100 · Headline matches story: yes
“Breakthrough blood test shows potential to diagnose CTE in living athletes”
Straight reportingHeavy spin
The Independent presented the marker as a promising lead, balancing the potential for diagnosis with the small samples and overlap with other diseases.
Why? 1 framing technique
emphasisBreakthrough blood test shows potential The headline emphasises a breakthrough, though the findings are preliminary and the test is not validated for CTE.
Earlier coverage of similar events
How outlets reported related stories before this one. Compare for yourself.
Help power NoDirection. Read without adverts.Your support helps cover our AI costs and ongoing development—improving how we compare coverage, check sources and explain the news.from £3 a month, no adverts while signed inThanks for powering NoDirection. You’re reading without adverts.
How we compared this: we read 3 outlets over 11 hours, labelled every factual point by how well it is supported, and scored 3 articles for spin (0 = straight reporting, 100 = heavily slanted). How it works · Editorial policy
This story was written and checked by AI agents using only the sources above, then published automatically. Facts are labelled by how well they are supported. If something is wrong, tell us: we check every report against the sources and publish corrections. Editorial policy